Axelspace Becomes the First Japanese Private Company Recognized as a Group on Earth Observations (GEO) Associate
Axelspace Holdings Corporation (“Axelspace Holdings”) is pleased to announce that its subsidiary, Axelspace Corporation, has been formally recognized as a Group on Earth Observations (GEO) Associate—the first private company from Japan to receive this distinction.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909494725/en/
GEO is a global partnership that brings together over 100 governments including Japan and more than 150 organizations from academia, business, and civil society. It produces user-driven Earth Intelligence solutions, which integrates Earth observation data, socioeconomic data, research and science, and other sources of information for empowering society to address critical global challenges.
Axelspace Corporation was recognized as a GEO Associate, which includes private sector entities, civil society organizations, and NGOs, at the GEO Executive Committee meeting in 2025. This recognition is expected to provide opportunities to share knowledge with participating governments–such as Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT), which is responsible for GEO in Japan–and participating organizations, gain insights into market needs, explore new business opportunities, and further strengthen international trust and presence of the company.
"Our group is starting to develop Earth observation solutions to help address various challenges faced by emerging countries, including those in Africa, through partnerships with these countries,” said Yuya Nakamura, President and CEO of Axelspace Holdings. "By building a win-win partnership with many emerging countries to co-create new value, we are committed to contributing to the long-term development of a robust global foundation for satellite data utilization.”
The Group on Earth Observations: https://earthobservations.org/
*Full release available here: https://www.axelspacehd.com/geo_associate/
Notice:
This document does not constitute any part of an offer to solicit investments in any securities. It is a press release intended for public disclosure and is not prepared for the purpose of soliciting investments, either in Japan or overseas.
Furthermore, this document does not constitute an offer to sell securities in the United States. The securities referred to in this document have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States unless they are registered under the Securities Act or an exemption from the registration requirements applies. The securities referred to in this document will not be publicly offered or sold in the United States.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250909494725/en/
Contacts
Media Contact
Axelspace Holdings Corporation
pr@axelspace.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress10.9.2025 14:30:00 EEST | Press release
Today Incyte (Nasdaq:INCY) announced that it will present new data from its dermatology portfolio at the European Association of Dermatology and Venerology (EADV) 2025 Congress, held from September 17 – 20, in Paris. Highlights include late-breaking, oral and poster presentations featuring data for povorcitinib (INCB054707), an oral small-molecule JAK1 inhibitor, and ruxolitinib cream (Opzelura®), a topical JAK1/2 inhibitor. “Our presence at EADV demonstrates the significant progress across our dermatology portfolio. The late-breaking data from the STOP-HS clinical trial program reinforce the potential of povorcitinib to benefit patients impacted by hidradenitis suppurativa (HS), a challenging and debilitating immune-mediated dermatologic condition,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “Data on ruxolitinib cream in new patient populations continues to demonstrate safety and efficacy in individuals with atopic dermatitis (AD), vitiligo an
Earnix Delivers on Promise of AI with Intelligent Decisioning Platform10.9.2025 14:00:00 EEST | Press release
At its Excelerate 2025 conference, Earnix, the leader in Dynamic AI for insurance, announced a new suite of solutions designed to help insurers fully realise the promise of AI. Built specifically for the insurance industry, these technologies accelerate decision-making and improve personalised customer experiences all while ensuring compliance in complex regulatory environments. For insurers, these Intelligent Decisioning capabilities unlock smarter, data-driven decision-making at scale. The platform delivers real-time insights and personalised offerings with faster speed-to-market, while maintaining robust governance of automated decisions. Customers benefit from: Improved profitability and risk management Stronger regulatory compliance and governance Enhanced customer satisfaction through personalised engagement Greater competitive positioning in a rapidly changing landscape The unified, no-code/low-code intelligent decisioning platform empowers business users to innovate rapidly wit
PsiQuantum Raises $1 Billion to Build Million-Qubit Scale, Fault-Tolerant Quantum Computers10.9.2025 14:00:00 EEST | Press release
PsiQuantum today announced it has raised $1 billion in funding for its Series E round to build the world’s first commercially useful, fault-tolerant quantum computers. This funding will equip the company to break ground on utility-scale quantum computing sites in Brisbane and Chicago, deploy large-scale prototype systems to validate systems architecture and integration, and further advance the performance of its quantum photonic chips and fault-tolerant architecture. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910135739/en/ Omega, PsiQuantum’s silicon photonic quantum chipset, designed by PsiQuantum and manufactured at GlobalFoundries’ Fab 8 in New York. Led by funds and accounts managed by affiliates of BlackRock, along with Temasek and Baillie Gifford, this fundraising values the company at $7 billion and brings in new investors, including entities administered by Macquarie Capital, Ribbit Capital, NVentures (NVIDIA’
Hitachi Digital Services Launches HARC Agents to Power Enterprise-Grade Agentic AI10.9.2025 13:00:00 EEST | Press release
Today, Hitachi Digital Services unveiled Hitachi Application Reliability Center Agents (HARC Agents), the company’s enterprise platform for trusted Agentic AI. The platform combines a full lifecycle of AI services – from concepting to deployment to optimization – to give customers a vital jump start on mission-critical innovations. A definitive demonstration of advanced automation and human-AI collaboration, HARC Agents enables Hitachi to equip enterprises with complex, scalable AI systems in 30% less time than typically required – significantly reducing time to value. HARC Agents is comprised of four primary AI resources: R202.ai: a framework for defining the development and deployment of scalable, enterprise-grade AI workloads in a reliable, responsible, observable, and optimal manner. HARC for AI: the Hitachi Application Reliability Center hosting professional and managed services that operationalize AI systems; ensuring they are always on, reliable, and cost optimized. Agent Librar
ROYC, Elvinger Hoss, and GDA: Strategic Fund Architecture – Capturing the Next Wave of Private Capital10.9.2025 10:45:00 EEST | Press release
ROYC, together with leading law firms Elvinger Hoss and GDA, today announced the publication of a joint white paper, Strategic Fund Architecture – Capturing the Next Wave of Private Capital. The report offers General Partners (GPs) and asset managers a practical roadmap to navigate Europe’s rapidly evolving fund structuring and distribution landscape. With ELTIF 2.0 now in force, AIFMD II implementation approaching, and the EU’s Savings & Investments Union (SIU) expected to channel trillions of euros of household savings into long-term private markets, fund structuring has become a board-level strategic priority. “Fund structuring is no longer just a back-office concern. Operational platforms and technology are now decisive in determining capital access, speed-to-market, and GP profitability,” said Mathias Leijon, Founder & President at ROYC. “This paper shows how integrating legal, operational, and technology architecture from day one transforms fund formation and lifecycle management
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom